Recombinant Vaccinia virus Protein C10 (C10L)

What is Vaccinia virus Protein C10 (C10L) and what is its role in viral pathogenesis?

C10L is an immunomodulatory protein encoded by the vaccinia virus genome that plays a significant role in viral evasion of host immune responses. It functions primarily by interfering with cellular antiviral pathways, particularly those involved in cytoplasmic DNA sensing. The protein is approximately 53 kDa in size and is expressed during the early phase of viral infection.

How is recombinant C10L protein typically produced in laboratory settings?

Production of recombinant C10L typically involves:

• Gene synthesis or PCR amplification of the C10L gene from vaccinia virus genomic DNA

• Cloning into an appropriate expression vector with a purification tag (His, GST, or MBP)

• Transformation into a suitable expression system (bacterial, insect, or mammalian)

• Optimization of expression conditions (temperature, induction time, media composition)

• Cell lysis and protein purification via affinity chromatography

• Secondary purification steps such as ion exchange or size exclusion chromatography

• Validation of protein identity and purity via SDS-PAGE and Western blotting

For functional studies, researchers must consider that prokaryotic systems may lack proper post-translational modifications required for full biological activity. Therefore, eukaryotic expression systems such as insect cells (using baculovirus vectors) or mammalian cells are often preferred for producing functionally active C10L protein, despite their lower yield compared to bacterial systems .

What expression systems are most suitable for producing functional recombinant C10L protein?

The choice of expression system depends on research objectives:

For structural studies, bacterial expression may suffice if properly optimized to avoid inclusion bodies. For functional immunological studies, mammalian expression is preferred to maintain native conformational epitopes and post-translational modifications that might be crucial for C10L's immunomodulatory functions .

What are the key structural features of C10L protein?

C10L belongs to the family of poxvirus immune evasion proteins with several notable structural features:

• N-terminal signal sequence for secretion or membrane targeting

• Conserved cysteine residues that form disulfide bonds critical for protein stability

• Structural motifs involved in protein-protein interactions with host immune factors

• Domains responsible for interfering with DNA sensing pathways

• Regions that show homology to other poxvirus immunomodulatory proteins

Researchers typically employ X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy to elucidate the three-dimensional structure of C10L. Computational approaches such as homology modeling can also provide insights, especially when comparing C10L to structurally characterized proteins with similar functions.

How can C10L protein be utilized in vaccine development strategies?

C10L's immunomodulatory properties make it relevant for vaccine development in several ways:

• Deletion approach: Removing C10L from vaccinia-based vaccine vectors can enhance immunogenicity by preventing viral suppression of innate immune responses. This approach has shown improved CD8+ T cell responses in preclinical models.

• Adjuvant potential: When properly formulated, C10L fragments can potentially serve as molecular adjuvants that modulate specific immune pathways.

• Chimeric vaccine design: Fusion of antigenic epitopes to modified C10L can direct immune responses toward specific pathways.

• Targeted delivery: C10L-based constructs can be engineered to target specific cell types involved in immune response generation.

Methodologically, researchers developing C10L-based vaccine strategies should:

• Evaluate immune response profiles using flow cytometry, ELISPOT, and cytokine profiling

• Assess protection in appropriate animal models

• Compare modified vectors with and without C10L to determine immunogenicity differences

• Monitor both innate and adaptive immune responses at different timepoints post-vaccination

How does C10L protein modulate the cGAS/STING pathway?

C10L belongs to a family of poxvirus proteins that can interfere with cytosolic DNA sensing pathways, particularly the cGAS/STING/IRF3 pathway. This pathway is critical for detecting cytoplasmic DNA (including viral genomes) and initiating interferon responses.

Mechanistically, C10L may function similarly to other described poxvirus proteins by:

• Directly inhibiting cGAS enzyme activity

• Degrading or sequestering cGAMP, the second messenger in this pathway

• Preventing STING dimerization or trafficking

• Interfering with downstream signaling components like TBK1 or IRF3

Recent research has identified "poxins" (cGAMP-specific nucleases) in poxviruses that specifically degrade cGAMP to prevent antiviral signaling. While the search results don't specifically identify C10L as a poxin, researchers investigating C10L should examine its potential role in this pathway .

Experimental approaches to study this include:

• In vitro enzymatic assays with purified C10L and cGAMP

• Cell-based reporter assays for STING activation

• Immunoprecipitation to identify C10L binding partners in the cGAS/STING pathway

• Comparison of interferon responses in cells infected with wild-type versus C10L-deficient viruses

What experimental approaches can be used to study C10L's immunomodulatory function?

Multiple complementary approaches can elucidate C10L's immunomodulatory functions:

• Genetic approaches:

  • CRISPR-Cas9 deletion/modification of C10L in viral genome

  • Generation of C10L point mutants to map functional domains

  • Complementation assays in C10L-deficient viral backgrounds

• Biochemical approaches:

  • Co-immunoprecipitation to identify host binding partners

  • Protein-protein interaction studies using techniques like BLI or SPR

  • In vitro enzymatic assays to test potential nuclease or signaling disruption activities

• Cellular immunology approaches:

  • Flow cytometry to assess impact on immune cell activation and phenotype

  • Cytokine profiling using multiplex assays

  • Transcriptomics to identify pathways modulated by C10L

  • Imaging studies to track C10L localization during infection

• In vivo approaches:

  • Animal infection models comparing wild-type and C10L-mutant viruses

  • Assessment of viral dissemination and pathogenesis

  • Analysis of immune cell infiltration and activation in infected tissues

These approaches should be combined for comprehensive characterization, moving from in vitro biochemical studies to cellular and ultimately in vivo models to establish physiological relevance.

How does C10L compare to other poxvirus immunomodulatory proteins?

Poxviruses encode multiple immunomodulatory proteins that target different aspects of host defense. Comparing C10L to these other factors:

Researchers investigating C10L should consider:

• Potential functional redundancy with other viral proteins

• Host-specific effects that may vary between model systems

• Context-dependent activities during different stages of infection

Comparative studies examining multiple viral immunomodulators simultaneously provide the most comprehensive understanding of how these factors collectively shape host-pathogen interactions.

What are the considerations for designing C10L-based chimeric proteins?

When designing C10L-based chimeric proteins for research or therapeutic applications, researchers should consider:

• Structural integrity:

  • Identifying domains that can be modified without disrupting core function

  • Using flexible linkers between C10L and fusion partners

  • Maintaining critical disulfide bonds and secondary structures

• Expression optimization:

  • Codon optimization for the intended expression system

  • Signal peptide selection for proper cellular localization

  • Inclusion of appropriate purification tags that don't interfere with function

• Functional validation:

  • Comparing immunomodulatory activity to wild-type C10L

  • Assessing the function of the fusion partner

  • Testing for unexpected interactions between domains

• Application-specific considerations:

  • For vaccine applications: enhancing immunogenicity without toxicity

  • For structural studies: incorporating stabilizing mutations

  • For targeting studies: adding cell-type specific targeting moieties

Methodologically, researchers should employ stepwise validation, testing chimeric constructs in cell-free systems before progressing to cellular assays and finally in vivo models when applicable.

What are the challenges in purifying biologically active recombinant C10L protein?

Purification of functionally active C10L presents several challenges:

• Solubility issues:

  • C10L may form inclusion bodies when overexpressed in bacteria

  • Solution: Use solubility-enhancing tags (MBP, SUMO), lower induction temperature, or switch to eukaryotic expression systems

• Proper folding and disulfide bond formation:

  • Incorrect disulfide bonding can lead to misfolded, non-functional protein

  • Solution: Express in oxidizing environments or refold using controlled redox conditions with a glutathione redox pair

• Aggregation during concentration:

  • Many viral proteins aggregate at higher concentrations

  • Solution: Include stabilizing agents (glycerol, arginine) in buffers; use staged dialysis approaches

• Proteolytic degradation:

  • C10L may be susceptible to proteolysis during purification

  • Solution: Include protease inhibitors; minimize purification time; keep samples cold

• Endotoxin contamination:

  • Critical for immunological studies

  • Solution: Include endotoxin removal steps; use endotoxin-free reagents

A successful purification strategy typically involves:

• Initial capture using affinity chromatography (His-tag or GST-tag)

• Intermediate purification using ion exchange chromatography

• Polishing step with size exclusion chromatography

• Validation of biological activity using functional assays specific to C10L's mechanism of action

How can researchers optimize C10L expression for structural biology studies?

For structural biology studies (X-ray crystallography, cryo-EM, or NMR), researchers need large quantities of highly pure, homogeneous protein:

• Construct optimization:

  • Create truncation constructs to remove disordered regions

  • Identify minimal functional domains through limited proteolysis

  • Introduce surface mutations to reduce conformational heterogeneity

  • Remove glycosylation sites that create heterogeneity

• Expression optimization:

  • Screen multiple expression systems (bacterial, insect, mammalian)

  • Test different fusion tags and their positions (N or C-terminal)

  • Optimize induction conditions (temperature, time, inducer concentration)

  • Consider specialized expression strains (e.g., SHuffle for disulfide bond formation)

• Purification refinements:

  • Implement on-column refolding for inclusion body-derived protein

  • Use crystallization chaperones or nanobodies to stabilize specific conformations

  • Employ buffer screening to identify stabilizing conditions

  • Consider heavy atom derivatives for phasing in crystallography

• Quality control metrics:

  • Thermal shift assays to assess protein stability

  • Dynamic light scattering to verify monodispersity

  • SEC-MALS to determine absolute molecular weight and oligomeric state

  • Negative-stain EM to visualize sample homogeneity

The success of structural studies often depends on rigorous construct optimization and the production of multiple variants to identify those most amenable to structural determination.

What are the current methodologies for analyzing C10L-host protein interactions?

Understanding C10L's interactions with host factors is crucial for elucidating its function. Current methodologies include:

• Unbiased identification approaches:

  • Immunoprecipitation coupled with mass spectrometry

  • Proximity labeling methods (BioID, APEX)

  • Yeast two-hybrid screening

  • Protein microarray screening

• Validation and characterization techniques:

  • Co-immunoprecipitation with candidate interactors

  • FRET/BRET to assess interactions in living cells

  • Surface plasmon resonance or biolayer interferometry for binding kinetics

  • Isothermal titration calorimetry for thermodynamic parameters

• Functional interaction mapping:

  • Mutagenesis to identify critical residues for interaction

  • Domain mapping through truncation constructs

  • Competition assays to identify binding sites

  • Crystal structures of protein complexes

• Cellular context assessment:

  • Proximity ligation assay to visualize interactions in situ

  • Live-cell imaging with fluorescently tagged proteins

  • Correlation of interaction with functional outcomes

  • Interactome changes during different stages of infection

When conducting interaction studies, researchers should consider both direct and indirect interactions, transient versus stable complexes, and the possibility that C10L may form different interaction networks depending on cellular context or infection stage.

How can C10L research contribute to improving poxvirus-based cancer therapeutics?

Poxviruses, particularly modified vaccinia viruses, are increasingly used as oncolytic agents and cancer vaccine vectors. C10L research can enhance these applications:

• Optimizing oncolytic activity:

  • C10L modification can potentially enhance anti-tumor immune responses

  • Deletion or modification of C10L may improve the immunogenicity of tumor-infected cells

  • Understanding C10L's interactions with cGAS/STING pathways can help design viruses that selectively replicate in cancer cells while stimulating immune recognition

• Enhancing cancer vaccines:

  • C10L-deleted viruses may serve as more potent vectors for tumor antigen delivery

  • The natural immunomodulatory properties of C10L could be redirected to enhance specific anti-tumor immune responses

  • Chimeric C10L proteins could be designed to target tumor-associated antigens to antigen-presenting cells

• Combination therapy approaches:

  • Understanding how C10L modulates immune pathways can inform rational combinations with checkpoint inhibitors

  • C10L-modified viruses might synergize with other immunotherapies by engaging complementary immune mechanisms

Research methodologies in this area should include:

• In vitro tumor cell line studies comparing wild-type and C10L-modified viruses

• Immune cell co-culture systems to assess cross-presentation of tumor antigens

• Animal models of cancer evaluating tumor regression and immune infiltration

• Analysis of immune memory formation following treatment with C10L-modified vectors

What is the role of C10L in virus-host interactions during infection?

C10L's role in virus-host interactions extends beyond immune evasion to potentially influence:

Research approaches should integrate:

• Systems biology approaches to map global effects of C10L on host cell networks

• In vivo imaging to track viral dissemination patterns

• Transcriptomics and proteomics to identify host pathways modulated by C10L

• Comparative studies across different host species to identify host-specific functions

How can CRISPR-Cas9 be used to study C10L function in infected cells?

CRISPR-Cas9 technology offers powerful approaches to study C10L function:

• Viral genome engineering:

  • Precise deletion or modification of C10L in the viral genome

  • Introduction of reporter tags for visualization

  • Creation of conditional C10L expression systems

  • Generation of chimeric C10L variants to map functional domains

• Host factor manipulation:

  • Knockout of candidate host interaction partners to confirm functional relationships

  • Creation of cell lines lacking specific immune pathways to test C10L's specificity

  • Engineering of host proteins resistant to C10L inhibition

• High-throughput screening:

  • Genome-wide CRISPR screens to identify host factors required for C10L function

  • Screens for factors that sensitize cells to C10L-deficient viruses

  • Pooled CRISPR libraries targeting potential C10L interaction partners

• In vivo CRISPR applications:

  • Creation of transgenic mouse models expressing C10L in specific tissues

  • Viral delivery of CRISPR components to modify C10L during active infection

  • Engineering of immune cells resistant to C10L immunomodulation

Methodological considerations include:

• Design of specific gRNAs with minimal off-target effects

• Validation of editing efficiency using sequencing and functional assays

• Complementation studies to confirm phenotypes are specifically due to C10L loss

• Development of appropriate readouts to quantify C10L's effects

What are the emerging technologies that could advance C10L research?

Several cutting-edge technologies are poised to transform C10L research:

• Single-cell approaches:

  • Single-cell RNA-seq to characterize heterogeneity in host responses to C10L

  • Single-cell proteomics to identify cell-specific protein interactions

  • Spatial transcriptomics to map C10L effects in tissues during infection

• Advanced structural methods:

  • Cryo-electron tomography to visualize C10L in its native cellular context

  • Integrative structural biology combining multiple data types

  • AlphaFold and related AI approaches for structure prediction

• Organoid and microphysiological systems:

  • Human tissue-specific organoids to study C10L function in relevant cell types

  • Organ-on-chip approaches to model complex tissue responses

  • Immune organoids to assess C10L effects on developing immune responses

• Synthetic biology:

  • Creation of minimal synthetic poxviruses with defined immunomodulatory capacities

  • Engineering orthogonal C10L variants with novel functions

  • Development of C10L-based synthetic immunomodulatory circuits